These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22972489)

  • 1. Are polymorphisms of the β(3)-adrenoceptor gene associated with an altered bladder function?
    Teitsma CA; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2013 Mar; 32(3):276-80. PubMed ID: 22972489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
    Helfand BT; Hu Q; Loeb S; McVary KT; Catalona WJ
    J Urol; 2013 Mar; 189(3):845-8. PubMed ID: 23159463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between polymorphism of beta3-adrenoceptor gene and overactive bladder.
    Honda K; Yamaguchi O; Nomiya M; Shishido K; Ishibashi K; Takahashi N; Aikawa K
    Neurourol Urodyn; 2014 Apr; 33(4):400-2. PubMed ID: 24038238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of β
    Haga N; Okabe Y; Miyazaki T; Tsubouchi K; Akaihata H; Hata J; Honda R; Matsuoka K; Ogawa S; Kojima Y
    World J Urol; 2021 Aug; 39(8):3035-3040. PubMed ID: 33398425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between expression of β3-adrenoceptor mRNA in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms.
    Kurizaki Y; Ishizuka O; Imamura T; Ishikawa M; Ichino M; Ogawa T; Nishizawa O; Andersson KE
    Neurourol Urodyn; 2013 Jan; 32(1):88-91. PubMed ID: 22692629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the factors contributing to failure in improvement of subjective symptoms following silodosin administration in patients with benign prostatic hyperplasia? Investigation using a pressure-flow study.
    Matsukawa Y; Hattori R; Sassa N; Yamamoto T; Gotoh M
    Neurourol Urodyn; 2013 Mar; 32(3):266-70. PubMed ID: 22907775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.
    Mochtar CA; Laan W; Van Houwelingen KP; Franke B; De La Rosette JJ; Schalken JA; Kiemeney LA
    BJU Int; 2006 Apr; 97(4):852-5. PubMed ID: 16536786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the H19 gene and the risk of bladder cancer.
    Verhaegh GW; Verkleij L; Vermeulen SH; den Heijer M; Witjes JA; Kiemeney LA
    Eur Urol; 2008 Nov; 54(5):1118-26. PubMed ID: 18262338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of bladder function in benign prostatic hyperplasia].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1992 Oct; 38(10):1135-8. PubMed ID: 1282773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis.
    Qu HC; Zhang W; Liu YL; Wang P
    Genet Mol Res; 2015 Mar; 14(1):2495-501. PubMed ID: 25867395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic polymorphisms in the pore domains of mechano-gated TREK-1 channel with overactive lower urinary tract symptoms in humans.
    Nedumaran B; Pineda RH; Rudra P; Lee S; Malykhina AP
    Neurourol Urodyn; 2019 Jan; 38(1):144-150. PubMed ID: 30350878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011.
    Oelke M; Kirschner-Hermanns R; Thiruchelvam N; Heesakkers J
    Neurourol Urodyn; 2012 Mar; 31(3):322-6. PubMed ID: 22415947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between expression of α(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms.
    Kurizaki Y; Ishizuka O; Imamura T; Ichino M; Ogawa T; Igawa Y; Nishizawa O; Andersson KE
    Scand J Urol Nephrol; 2011 Feb; 45(1):15-9. PubMed ID: 20961266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with increased small dense low-density lipoprotein in a rural Japanese population: the Mima study.
    Tsuzaki K; Kotani K; Fujiwara S; Sano Y; Matsuoka Y; Domichi M; Hamada T; Shimatsu A; Sakane N
    Metabolism; 2007 Dec; 56(12):1689-93. PubMed ID: 17998022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.